|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 11.36 USD | +0.89% |
|
-2.24% | -44.20% |
| 09-08 | Keros Therapeutics Approves $5 Million Share Buyback | MT |
| 09-08 | Keros Therapeutics, Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 225M | - | - | - | ||
| 74.16B | |||||
| 57.39B | |||||
| 47.64B | |||||
| 44.29B | - | - | - | - | - |
| 42.5B |
Select your edition
All financial news and data tailored to specific country editions
